Gomekli Tablet, For Suspension
Product Images NDC 82448-134

Product Visual Gallery

This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Gomekli (NDC 82448-134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Springworks Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gomekli Capsules And Tablets For Oral Suspension Contain Mirdametinib, A Kinase Inhibitor. Mirdametinib Is Chemically Known As (r)-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2- Fluoro-4-iodophenyl)amino) Benzamide. The Molecular Formula Is C16h14 F3in2o4 And The Molecular Weight Is 482.20 G/mol. The Structural Formula For Mirdametinib Is: (Mirdametinib Tablet 01)

FDA Label Image

Step 2 (Mirdametinib Tablet 02)

FDA Label Image

Step 3 (Mirdametinib Tablet 03)

FDA Label Image

Step 4 (Mirdametinib Tablet 04)

FDA Label Image

Step 5 (Mirdametinib Tablet 05)

FDA Label Image

2-4 Min (Mirdametinib Tablet 06)

FDA Label Image

Step A1 (Mirdametinib Tablet 07)

FDA Label Image

Step A2 (Mirdametinib Tablet 08)

FDA Label Image

Step A3 (Mirdametinib Tablet 09)

FDA Label Image

Step A4 (Mirdametinib Tablet 0a)

FDA Label Image

Step A5 (Mirdametinib Tablet 0b)

FDA Label Image

Step B1 (Mirdametinib Tablet 0c)

FDA Label Image

Step B2 (Mirdametinib Tablet 0d)

FDA Label Image

Step B3 (Mirdametinib Tablet 0e)

FDA Label Image

Step B4 (Mirdametinib Tablet 0f)

FDA Label Image

Step B5 (Mirdametinib Tablet 10)

FDA Label Image

Step B6 (Mirdametinib Tablet 11)

FDA Label Image

Step B7 (Mirdametinib Tablet 12)

FDA Label Image

Principal Display Panelndc 82448-134-84gomeklitm (mirdametinib) Tablets For Oral Suspension1 mgper Tablet84 Tablets (Mirdametinib Tablet 13)

FDA Label Image

Principal Display Panelndc 82448-134-84gomeklitm (mirdametinib) Tablets For Oral Suspension1 mgper Tablet84 Tablets (Mirdametinib Tablet 14)

FDA Label Image

Principal Display Panelndc 82448-134-42gomeklitm (mirdametinib) Tablets For Oral Suspension1 mgper Tablet42 Tablets (Mirdametinib Tablet 15)

FDA Label Image

Principal Display Panelndc 82448-134-42gomeklitm (mirdametinib) Tablets For Oral Suspension1 mgper Tablet42 Tablets (Mirdametinib Tablet 16)

FDA Label Image

Principal Display Panelndc 82448-130-42gomeklitm (mirdametinib) Capsules1 mgper Capsules42 Capsules (Mirdametinib Tablet 17)

FDA Label Image

Principal Display Panelndc 82448-130-42gomeklitm (mirdametinib) Capsules1 mgper Capsules42 Capsules (Mirdametinib Tablet 18)

FDA Label Image

Principal Display Panelndc 82448-260-42gomeklitm (mirdametinib) Capsules2 mgper Capsules42 Capsules (Mirdametinib Tablet 19)

FDA Label Image

Principal Display Panelndc 82448-260-42gomeklitm (mirdametinib) Capsules2 mgper Capsules42 Capsules (Mirdametinib Tablet 1a)

FDA Label Image

Principal Display Panelndc 82448-260-84gomeklitm (mirdametinib) Capsules2 mgper Capsules84 Capsules (Mirdametinib Tablet 1b)

FDA Label Image

Principal Display Panelndc 82448-260-84gomeklitm (mirdametinib) Capsules2 mgper Capsules84 Capsules (Mirdametinib Tablet 1c)